Key statistics
As of last trade, Iovance Biotherapeutics Inc (2LB:FRA) traded at 10.05, 173.92% above the 52 week low of 3.67 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.80 |
---|---|
High | 10.05 |
Low | 9.80 |
Bid | 9.91 |
Offer | 10.06 |
Previous close | 9.10 |
Average volume | 7.38k |
---|---|
Shares outstanding | 303.51m |
Free float | 274.71m |
P/E (TTM) | -- |
Market cap | 3.21bn USD |
EPS (TTM) | -1.50 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 08:57 GMT.
More ▼
Announcements
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
- Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
- Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics to Present at Upcoming Conferences and Events
- Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
- Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
More ▼